Merck is back in Alzheimer's saddle with $1B+ Cerevance pact, years after dropping the BACE

Another Big Pharma is entering—or rather re-entering—the Alzheimer’s ring. Merck & Co. has signed a billion-dollar biobucks deal with Cerevance to identify new therapies for the devastating neurodegenerative disease.